These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 3011261)

  • 21. [Taxol in small-cell and non-small-cell bronchial carcinoma].
    Med Klin Suppl; 1993 Nov; 2():14. PubMed ID: 7904715
    [No Abstract]   [Full Text] [Related]  

  • 22. Phase II trial of AMSA in patients with refractory small cell carcinoma of the lung.
    Fuks JZ; Van Echo DA; Aisner J; Von Hoff D; Wiernik PH
    Cancer Treat Rep; 1981; 65(1-2):133-4. PubMed ID: 6261947
    [No Abstract]   [Full Text] [Related]  

  • 23. Phase II evaluation of aclarubicin in lung cancer: a Southeastern Cancer Study Group Trial.
    Kramer BS; Birch R; Gockerman JP; Greco A; Prestridge K
    Cancer Treat Rep; 1986 Jun; 70(6):803-4. PubMed ID: 3015404
    [No Abstract]   [Full Text] [Related]  

  • 24. [Cisplatin, peplomycin, mitomycin C, and vincristine combination chemotherapy of non-small cell carcinoma of the lung].
    Saito H; Nomura F; Kawatsu H; Sakai S; Kobayashi T; Shimokata K
    Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 2):2715-8. PubMed ID: 6210062
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Phase II study of teniposide in small cell carcinoma of the lung.
    Pedersen AG; Bork E; Osterlind K; Dombernowsky P; Hansen HH
    Cancer Treat Rep; 1984 Oct; 68(10):1289-91. PubMed ID: 6098366
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [A phase II study of vindesine for pretreated non-small cell lung cancer].
    Shimizu E; Nakamura Y; Yamasaki K; Kimura K; Inoue I; Nakahira S; Kawahito K; Tani K; Sone S; Yamashita T
    Gan To Kagaku Ryoho; 1987 Aug; 14(8):2532-6. PubMed ID: 3039921
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Preliminary phase II study of cis-Dichlorodiammineplatinum (II) in patients with non-small cell carcinoma of the lung and metastatic pulmonary tumor].
    Tominaga K; Saijo N; Eguchi K; Shinkai T; Shimizu E
    Gan No Rinsho; 1984 Sep; 30(11):1344-50. PubMed ID: 6094880
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phase II trial of mitomycin-C in patients with small cell carcinoma of the lung after failure on combination chemotherapy.
    Joss RA; Obrecht JP; Senn HJ; Alberto P; Sauter C; Cavalli F
    Eur J Cancer Clin Oncol; 1984 Dec; 20(12):1477-9. PubMed ID: 6094197
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A phase II trail of vindesine in patients with refractory small-cell carcinoma of the lung.
    Fuks JZ; Aisner J; Carney DN; Van Echo DA; Ostrow SS; Ihde DC; Wiernik PH
    Am J Clin Oncol; 1982 Feb; 5(1):49-52. PubMed ID: 6282108
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phase II evaluation of vindesine in non-small cell bronchogenic carcinoma.
    Hutcheon AW; Palmer JB; Pratt MA; Clark RA
    Cancer Treat Rep; 1983 Nov; 67(11):1041-2. PubMed ID: 6315231
    [No Abstract]   [Full Text] [Related]  

  • 31. [Multidisciplinary treatment for small cell lung cancer].
    Saijo N; Eguchi K; Shimizu E; Shinkai T; Tominaga K; Takahashi K; Sasaki Y; Seki S
    Gan To Kagaku Ryoho; 1984 Mar; 11(3):474-9. PubMed ID: 6322700
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Polychemotherapy of small-cell lung cancer].
    Krawczyk K; Krochmal M; Pawlicki M; Kulpa J
    Pneumonol Pol; 1983 Feb; 51(2):101-5. PubMed ID: 6308583
    [No Abstract]   [Full Text] [Related]  

  • 33. Phase II evaluation of triazinate in patients with metastatic lung cancer.
    Creagan ET; Eagan RT; Fleming TR; Frytak S; Ingle JN; Kvols LK; Nichols WC
    Cancer Treat Rep; 1980; 64(10-11):1057-9. PubMed ID: 6257389
    [No Abstract]   [Full Text] [Related]  

  • 34. [Results of chemotherapy of patients with lung cancer].
    Pawlicki M; Krawczyk K; Krochmal M; Sokołowski A; Zielezińska A
    Pneumonol Pol; 1986 Jun; 54(6):227-30. PubMed ID: 3027677
    [No Abstract]   [Full Text] [Related]  

  • 35. Alternating chemotherapy with etoposide plus cisplatin and topotecan plus paclitaxel in patients with untreated, extensive-stage small cell lung carcinoma: a phase II trial of the North Central Cancer Treatment Group.
    Jett JR; Hatfield AK; Hillman S; Bauman MD; Mailliard JA; Kugler JW; Morton RF; Marks RS; Levitt R
    Cancer; 2003 May; 97(10):2498-503. PubMed ID: 12733149
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of peplomycin plus carbazilquinone and mitomycin on non-small cell carcinoma of the lung.
    Saijo N; Shimizu E; Eguchi K; Shinkai T; Tominaga K; Shibuya M; Shimabukuro Z; Niitani H; Hoshi A
    Cancer Treat Rep; 1983 Apr; 67(4):385-7. PubMed ID: 6189601
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Combination chemotherapy with cis-platinum, adriamycin and mitomycin C (PAM) in the treatment of non-small cell carcinoma of the lung].
    Nakano H; Kurihara M; Saito R; Takise A; Tsuchiya S; Minato K; Takehara K; Saruya T; Kuwabara H; Fueki R
    Gan To Kagaku Ryoho; 1986 Jun; 13(6):2123-7. PubMed ID: 3013099
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Combination chemotherapy with etoposide, mitomycin C, and cyclophosphamide in advanced non-small cell lung cancer].
    Homma T; Yoneda S; Fukuda Y; Nakata M; Noguchi Y; Yoshida S
    Gan To Kagaku Ryoho; 1986 Jul; 13(7):2399-403. PubMed ID: 3015045
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Comprehensive evaluation of treatment outcome of various therapies in 508 cases of small cell lung cancer].
    Zhang Y; Gu YF; Deng LH; Yang SS; Li SY
    Zhonghua Yi Xue Za Zhi; 2004 Jun; 84(11):917-9. PubMed ID: 15329278
    [No Abstract]   [Full Text] [Related]  

  • 40. [Chemotherapy of advanced non-small-cell and small-cell bronchial carcinoma with bendamustine--a phase II study].
    Reck M; Haering B; Koschel G; Kaukel E; von Pawel J; Gatzemeier U
    Pneumologie; 1998 Oct; 52(10):570-3. PubMed ID: 9847635
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.